#pharmaceutical-patents
#pharmaceutical-patents

[ follow ]

Clinical Efficacy a Functionally Unrelated Limitation That Creates No Patentability, CAFC Finds

The Federal Circuit affirmed-in-part the PTAB's invalidation of Bayer's patent claims and rejected a separate clinical-efficacy requirement for "clinically proven effective".

Medicine

fromIPWatchdog.com | Patents & Intellectual Property Law

1 week ago

Amgen Attacks Academics' False Claims About Biologic Patents

The current pharmaceutical patent system is working and innovation is benefiting actual patients.

Intellectual property law

fromIntellectual Property Law Blog

1 month ago

Claiming A Range, Watch Out For The Presumption Of Obviousness

Disclosure of a broad prior-art dose range does not automatically render narrower claimed dosing regimens obvious without a demonstrated reason to select the claimed doses.

Intellectual property law

fromIPWatchdog.com | Patents & Intellectual Property Law

3 months ago

USPTO Study into Applications with Large Patent Families Raises Questions

The USPTO study revealed widespread use of terminal disclaimers and amendments in response to omitted double patenting rejections.

Concerns over 'patent thickets' in pharmaceuticals led to a five-year study by the USPTO.

[ Load more ]

#pharmaceutical-patents#pharmaceutical-patents

Clinical Efficacy a Functionally Unrelated Limitation That Creates No Patentability, CAFC Finds

Amgen Attacks Academics' False Claims About Biologic Patents

Claiming A Range, Watch Out For The Presumption Of Obviousness

USPTO Study into Applications with Large Patent Families Raises Questions

#pharmaceutical-patents
#pharmaceutical-patents